Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy (vol 13, 997314, 2023)

被引:0
作者
Li, Qian [1 ,2 ]
Ma, Fei [2 ,3 ]
Wang, Ju Feng [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Oncol, Zhengzhou, Peoples R China
[2] Henan Canc Hosp, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Canc Hosp, Dept Gen Surg, Zhengzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
advanced lung cancer inflammatory index (ALI); hepatocellular carcinoma; Immunotherapy; nomogram; prognosis;
D O I
10.3389/fonc.2024.1431058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
    Chon, Young Eun
    Cheon, Jaekyung
    Kim, Hyeyeong
    Kang, Beodeul
    Ha, Yeonjung
    Kim, Do Young
    Hwang, Seong Gyu
    Chon, Hong Jae
    Kim, Beom Kyung
    CANCER MEDICINE, 2023, 12 (03): : 2731 - 2738
  • [42] Establishing a signature based on immunogenic cell death-related gene pairs to predict immunotherapy and survival outcomes of patients with hepatocellular carcinoma
    Ma, Jianying
    Kuang, Lianghong
    Zhao, Rong
    AGING-US, 2022, 14 (23): : 9699 - 9714
  • [43] Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
    Topkan, Erkan
    Mertsoylu, Huseyin
    Ozdemir, Yurday
    Sezer, Ahmet
    Kucuk, Ahmet
    Besen, Ali Ayberk
    Ozyilkan, Ozgur
    Selek, Ugur
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8807 - 8815
  • [44] Comprehensive nutritional index predicts clinical outcomes for esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy
    Feng, Jifeng
    Wang, Liang
    Yang, Xun
    Chen, Qixun
    Cheng, Xiangdong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [45] Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With Immunotherapy
    Sun, Lova
    Aggarwal, Charu
    CANCER JOURNAL, 2020, 26 (06) : 548 - 554
  • [46] A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma
    Wang, Lu
    Wang, Cong
    Wang, Jiangfeng
    Huang, Xiaochen
    Cheng, Yufeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (10) : 2077 - 2086
  • [47] Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
    Gardini, Andrea Casadei
    Scarpi, Emanuela
    Faloppi, Luca
    Scartozzi, Mario
    Silvestris, Nicola
    Santini, Daniele
    de Stefano, Giorgio
    Marisi, Giorgia
    Negri, Francesca V.
    Foschi, Francesco Giuseppe
    Valgiusti, Martina
    Ercolani, Giorgio
    Frassineti, Giovanni Luca
    ONCOTARGET, 2016, 7 (41) : 67142 - 67149
  • [48] Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis
    Zhou, Ke
    Cao, Jie
    Lin, Huahang
    Liang, Linchuan
    Shen, Zhongzhong
    Wang, Lei
    Peng, Zhiyu
    Mei, Jiandong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
    Qi Wang
    Wenying Qiao
    Biyu Liu
    Jianjun Li
    Chunwang Yuan
    Jiang Long
    Caixia Hu
    Chaoran Zang
    Jiasheng Zheng
    Yonghong Zhang
    BMC Gastroenterology, 22
  • [50] The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy
    Zhang, Lilong
    Zhao, Kailiang
    Kuang, Tianrui
    Wang, Kunpeng
    Chai, Dongqi
    Qiu, Zhendong
    Liu, Rongqiang
    Deng, Wenhong
    Wang, Weixing
    BMC CANCER, 2023, 23 (01)